RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
RPTP was delisted on the 24th of October, 2016.
93 hedge funds and large institutions have $252M invested in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in 2016 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 36 increasing their positions, 23 reducing their positions, and 19 closing their positions.
57% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 23
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
21% more capital invested
Capital invested by funds: $209M → $252M (+$43.5M)
16% more call options, than puts
Call options by funds: $4.17M | Put options by funds: $3.58M
4% less funds holding
Funds holding: 97 → 93 (-4)
21% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 19
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Atika Capital Management
New York
|
+$6.96M |
| 2 |
HM
HealthCor Management
New York
|
+$5.39M |
| 3 |
GTC
Ghost Tree Capital
New York
|
+$3.08M |
| 4 |
State Street
Boston,
Massachusetts
|
+$2.97M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
+$1.85M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$5.75M |
| 2 |
BC
Broadfin Capital
New York
|
-$2.82M |
| 3 |
Renaissance Technologies
New York
|
-$2.64M |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$1.89M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$1.84M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
101
DekaBank Deutsche Girozentrale
Frankfurt,
Germany
| – | -$172K | -39,000 | Closed |
|
102
SG Americas Securities
New York
| – | -$111K | -24,140 | Closed |
|
|
AL
103
Airain Ltd
St. Peter Port,
Guernsey
| – | -$102K | -22,170 | Closed |
|
|
SCM
104
Stonepine Capital Management
Bend,
Oregon
| – | -$92K | -20,000 | Closed |
|
|
NIT
105
NumerixS Investment Technologies
Vancouver,
British Columbia, Canada
| – | -$77K | -16,691 | Closed |
|
|
VKH
106
Virtu KCG Holdings
New York
| – | -$63K | -13,722 | Closed |
|
107
M&T Bank
Buffalo,
New York
| – | -$47K | -10,244 | Closed |
|
|
BPC
108
Banque Pictet & Cie
Geneva 73,
Switzerland
| – | -$46K | -10,000 | Closed |
|
|
TRCT
109
Tower Research Capital (TRC)
New York
| – | -$1K | -257 | Closed |
|
110
Barclays
London,
United Kingdom
| – | -$62 | -12 | Closed |
|
RPTP Hedge Fund Activity: Q2 2016 in Review
93 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) for Q2 2016, worth a combined $252M — up 21% from $209M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of RPTP and 15 opened new positions — a net loss of 4 holders — while 23 trimmed existing stakes and 36 added.
The largest buyer was Atika Capital Management, opening a new position worth an estimated $6.96M. The largest seller was Millennium Management, cutting an estimated $5.75M.
- 93 institutional investors held RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) as of Q2 2016, down from 97 in Q1 2016.
- Funds reported $252M of RAPTOR PHARMACEUTICAL CORP COM STK (DE) stock for Q2 2016, up 21% quarter-over-quarter.
- 15 funds opened new RAPTOR PHARMACEUTICAL CORP COM STK (DE) positions in Q2 2016 and 19 closed out, a net change of -4 holders.
- The largest RAPTOR PHARMACEUTICAL CORP COM STK (DE) buyer in Q2 2016 was Atika Capital Management, an estimated $6.96M added.
- The largest RAPTOR PHARMACEUTICAL CORP COM STK (DE) seller in Q2 2016 was Millennium Management, an estimated $5.75M sold.
Based on aggregated 13F filings for Q2 2016.